RBC Capital: 'Chemours (CC) Remains Our Favorite Name in the Group'; PT Lowered
Tweet Send to a Friend
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $17.00 (from $25.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
